Medications

Experimental drug shields pancreas from type 1 diabetes attack

Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals' ...

Diabetes

Adding AI to artificial pancreas enhances efficiency, study finds

Adding advanced artificial intelligence to an artificial pancreas regulating type 1 diabetes is safe and improves the system's efficiency, a first-of-its-kind study from the University of Virginia Center for Diabetes Technology ...